LIMP-2 Protein

LIMP-2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LIMP-2 Protein</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysosomal Integral Membrane Protein 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCARB2 (Scavenger Receptor Class B Member 2)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CD36 superfamily (scavenger receptor family)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Chromosome 4q21.1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>78.5 kDa</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Lysosomal transporter, glucocerebrosidase receptor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>

LIMP-2 Protein

Overview

LIMP-2 (Lysosomal Integral Membrane Protein 2), encoded by the SCARB2 (Scavenger Receptor Class B Member 2) gene, is a major lysosomal membrane protein that plays critical roles in lysosomal function, lipid metabolism, and cellular homeostasis. LIMP-2 is a type III transmembrane protein with a large lumenal domain and a short cytoplasmic tail, and it is widely expressed in various tissues including the brain[@eskelinen2002][@rechsteiner2015].

LIMP-2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LIMP-2 Protein</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysosomal Integral Membrane Protein 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCARB2 (Scavenger Receptor Class B Member 2)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CD36 superfamily (scavenger receptor family)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Chromosome 4q21.1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>78.5 kDa</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Lysosomal transporter, glucocerebrosidase receptor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>

LIMP-2 Protein

Overview

LIMP-2 (Lysosomal Integral Membrane Protein 2), encoded by the SCARB2 (Scavenger Receptor Class B Member 2) gene, is a major lysosomal membrane protein that plays critical roles in lysosomal function, lipid metabolism, and cellular homeostasis. LIMP-2 is a type III transmembrane protein with a large lumenal domain and a short cytoplasmic tail, and it is widely expressed in various tissues including the brain[@eskelinen2002][@rechsteiner2015].

One of the most important functions of LIMP-2 is its role as a specific receptor for the lysosomal enzyme glucocerebrosidase (GCase, encoded by GBA). LIMP-2 binds GCase in the endoplasmic reticulum and transports it to lysosomes. This function connects LIMP-2 directly to [Parkinson's disease](/diseases/parkinsons-disease), as GBA mutations are among the most significant genetic risk factors for PD[@markmann2017].

Mutations in SCARB2 cause a rare lysosomal storage disorder characterized by progressive myoclonic epilepsy, ataxia, and demyelination—a condition now classified as a form of neuronal ceroid lipofuscinosis (NCL)[@blanzach2010][@gennarino2019]. This demonstrates the critical importance of LIMP-2 for normal neuronal function.

Gene Structure and Expression

Gene Organization

The SCARB2 gene is located on chromosome 4q21.1 and spans approximately 22 kb. It consists of 16 exons encoding a 478-amino acid protein with a molecular weight of approximately 78.5 kDa[@stoa2019].

Protein Structure

LIMP-2 has a characteristic type III transmembrane topology:

N-terminal Cytoplasmic Domain: Approximately 10 amino acids containing trafficking signals.

Transmembrane Helices: Two membrane-spanning domains anchor LIMP-2 in the lysosomal membrane.

Lumenal Domain: The large extracellular/lumenal region (~380 amino acids) contains multiple N-linked glycosylation sites and forms the functional domains involved in protein interactions.

Tissue Distribution

LIMP-2 is expressed in most tissues with highest levels in:

• Brain: Neurons, microglia, and oligodendrocytes
• Kidney: Proximal tubules
• Liver: Hepatocytes
• Spleen and immune cells
• Muscle

Biological Functions

Lysosomal Enzyme Transport

The primary function of LIMP-2 is to act as a specific receptor for glucocerebrosidase (GCase)[@blanzach2010][@rechsteiner2015]:

ER to Lysosome Transport: LIMP-2 binds newly synthesized GCase in the endoplasmic reticulum and escorts it through the Golgi to lysosomes. This interaction is highly specific—LIMP-2 does not transport other lysosomal enzymes.

Intracellular Trafficking: The LIMP-2/GCase complex follows the mannose-6-phosphate-independent trafficking pathway to lysosomes.

Enzyme Delivery: Once in lysosomes, GCase dissociates from LIMP-2 and becomes active. LIMP-2 is then recycled back to the lysosomal membrane.

This pathway is essential for maintaining normal GCase activity in lysosomes. Loss of LIMP-2 function leads to GCase deficiency and accumulation of its substrate, glucosylceramide.

Lysosomal Membrane Organization

LIMP-2 contributes to lysosomal membrane composition and function[@eskelinen2002][@stoa2019]:

Membrane Proteins: LIMP-2 is one of the most abundant proteins in the lysosomal membrane.

Lysosomal Stability: Helps maintain lysosomal integrity and function.

Luminal pH: Affects lysosomal acidification and enzyme activity.

Lipid Metabolism

LIMP-2 plays important roles in cellular lipid handling[@avrahami2021]:

Cholesterol Transport: Involved in cellular cholesterol efflux and metabolism.

Glycolipid Processing: Through its role in GCase transport, affects glycosphingolipid catabolism.

Membrane Composition: Influences lysosomal membrane lipid composition.

Autophagy

LIMP-2 participates in autophagy and lysosomal degradation pathways[@schrader2018][@yamashita2020]:

Autophagosome-Lysosome Fusion: Facilitates the fusion of autophagosomes with lysosomes.

Substrate Clearance: Enables degradation of autophagy substrates including protein aggregates.

Lysosomal Biogenesis: Contributes to lysosome formation and function.

Role in Neurodegenerative Diseases

Parkinson's Disease

LIMP-2 has emerged as an important player in Parkinson's disease through its role in GCase trafficking[@markmann2017][@barcelo2018][@rong2021]:

GBA Link: Because LIMP-2 is required for proper GCase localization to lysosomes, it directly affects the enzyme activity that is compromised in GBA mutation carriers—the most common genetic risk factor for PD.

Alpha-synuclein Metabolism: GCase activity is linked to alpha-synuclein degradation. Reduced GCase activity due to LIMP-2 dysfunction may contribute to alpha-synuclein aggregation, the hallmark pathology of PD.

Genetic Studies: SCARB2 polymorphisms have been associated with PD risk in some genetic studies, though the evidence is less strong than for GBA.

Lysosomal Dysfunction: LIMP-2 deficiency leads to lysosomal impairment, which is a common feature of PD pathogenesis.

Therapeutic Implications: Enhancing LIMP-2 function or GCase trafficking may represent a therapeutic strategy for PD, particularly in patients with GBA mutations.

Neuronal Ceroid Lipofuscinosis (NCL)

Biallelic mutations in SCARB2 cause a form of NCL, also known as CLN8 disease or "EPMR" (Epilepsy with Progressive Myoclonus)[@blanzach2010][@gennarino2019][@sandahl2021]:

Clinical Features: Progressive myoclonic epilepsy, ataxia, cognitive decline, and visual impairment. Onset is typically in childhood or adolescence.

Pathology: Accumulation of lipofuscin-like material in neurons and other cell types.

Mechanism: Loss of LIMP-2 function leads to impaired lysosomal enzyme delivery and subsequent lysosomal storage.

Animal Models: Mouse models of LIMP-2 deficiency recapitulate key features of the human disease.

Alzheimer's Disease

LIMP-2 has potential relevance to Alzheimer's disease through several mechanisms[@defelice2020]:

Lysosomal Function: Impaired lysosomal function contributes to amyloid-beta accumulation and tau pathology.

GCase Activity: Links to GBA-related pathways that may intersect with AD pathogenesis.

Lipid Metabolism: Cholesterol and lipid dysregulation are features of AD.

Autophagy: Impaired autophagic clearance of amyloid-beta and tau.

Other Neurodegenerative Conditions

LIMP-2 may be implicated in:

Gaucher Disease: While caused by GBA mutations, LIMP-2 dysfunction may modify disease severity.

Multiple System Atrophy: Lysosomal dysfunction is a feature of this synucleinopathy.

Huntington's Disease: Autophagy and lysosomal pathways are affected.

Mechanisms in Neurodegeneration

Lysosomal Dysfunction

LIMP-2 deficiency leads to primary lysosomal impairment[@rechsteiner2015]:

Enzyme Deficiency: Loss of GCase activity in lysosomes.

Substrate Accumulation: Glucosylceramide and other glycolipids accumulate.

Impaired Degradation: Reduced capacity to degrade proteins and organelles.

Autophagy Block: Disrupted autophagosome-lysosome fusion.

Calcium Homeostasis

LIMP-2 affects lysosomal calcium handling[@krumova2011]:

Calcium Storage: Lysosomes serve as calcium stores.

Calcium Release: LIMP-2 modulates calcium release from lysosomes.

Signaling: Affected calcium signaling may influence neuronal function.

Neuroinflammation

LIMP-2 dysfunction may trigger neuroinflammatory responses[@zancanaro2021]:

Microglial Activation: Lysosomal dysfunction can activate microglia.

Immune Response: Affected immune cell function in the CNS.

Cytokine Production: Potential for increased inflammatory mediator production.

Research Methods

Genetic Studies

• Sequencing: Identifying SCARB2 mutations in patients
• Linkage Analysis: Genetic mapping of disease loci
• GWAS: Genome-wide association studies for PD risk

Protein Analysis

• Western Blot: Detecting LIMP-2 protein levels
• Immunohistochemistry: Localizing LIMP-2 in tissues
• ELISA: Quantifying soluble LIMP-2

Functional Studies

• GCase Activity Assays: Measuring enzymatic activity
• Lysosomal Function Tests: Assessing degradation capacity
• Cell Culture Models: Studying LIMP-2 knockdown/knockout cells
• Animal Models: Transgenic and knockout mice

Clinical Significance

Diagnostic Implications

LIMP-2 testing is relevant for:

NCL Diagnosis: SCARB2 mutations confirm a specific NCL subtype.

PD Risk Assessment: SCARB2 variants may modify PD risk.

Gaucher Disease: Understanding LIMP-2 status informs disease mechanisms.

Therapeutic Approaches

Targeting LIMP-2 represents potential therapeutic strategies[@kuronen2020]:

Enzyme Replacement: Approaches to enhance GCase delivery.

Gene Therapy: Delivering functional SCARB2.

Small Molecule Modulators: Enhancing LIMP-2 function or trafficking.

Substrate Reduction: Reducing GCase substrate accumulation.

Interactions and Pathways

Protein Interactions

Glucocerebrosidase (GBA): Primary interaction—LIMP-2 is the GCase receptor.

Other Lysosomal Proteins: May interact with other components of the lysosomal membrane.

Signaling Pathways

Lysosomal Biogenesis: TFEB and the CLEAR network.

Autophagy: mTOR and autophagy regulation.

Lipid Metabolism: LXR and PPAR pathways.

Animal Models

Knockout Mice

Scarb2 knockout mice exhibit:

• Glucosylceramide accumulation
• Lysosomal storage phenotype
• Neurological deficits
• Reduced GCase activity
• Premature death

Disease Models

• NCL models recapitulate human disease
• PD models show alpha-synuclein effects

Future Directions

Research Priorities

• Understanding LIMP-2 function in specific neuronal populations
• Developing therapeutic modulators
• Biomarker development for lysosomal disorders

Emerging Areas

• Gene therapy approaches
• Combination therapies targeting LIMP-2 and GCase
• Precision medicine for SCARB2-related disorders

Pathway & Interaction Diagram

Interactive diagram showing LIMP2's key relationships in the SciDEX knowledge graph (7 connections shown).

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease) — LIMP-2 and GCase link
• [Alpha-synuclein](/proteins/alpha-synuclein) — Protein aggregation in PD
• [Glucocerebrosidase](/proteins/glucocerebrosidase) — LIMP-2 cargo protein
• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders) — Disease category
• [Autophagy](/mechanisms/autophagy) — LIMP-2 in protein clearance

References

Pathway Diagram

The following diagram shows the key molecular relationships involving LIMP-2 Protein discovered through SciDEX knowledge graph analysis: